qsc retatrutide 60mg retatrutide | University of Peptides

What it is: A once-weekly injectable medication that activates receptors for GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon

Manage Cravings With a Weekly Pattern Mindset The most helpful way to understand retatrutide food noise is to look at weekly patterns instead of reacting to one difficult day

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors to promote weight loss and improve blood sugar control in obesity and type 2 diabetes

Vomiting is also common, reported in approximately 5-25% of patients depending on the specific medication and dose